Title: From Condoms to Brain Implants: Protecting Patient Safety Across the Device Spectrum Through Biological Assessment

Speakers: Thor Rollins, Audrey Turley

Date: 12/05/2017

Brief Description:
Using a risk-based approach to address biocompatibility has become mainstream, and actively encouraged by the FDA. This strategy allows manufacturers to leverage previous testing knowledge of device materials and chemistry to reduce their testing burden while improving patient safety. The caveat? Manufacturers have to better understand their materials and how they interact with the body.

Attachment: